Your AI-Trained Oncology Knowledge Connection!

Jennifer R. Diamond, MD

home / authors / jennifer-r-diamond-md

Articles

Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer

Jennifer Weiss, MD;Anosheh Afghahi, MD;Elena Shagisultanova, MD, PhD;Jennifer R. Diamond, MD

October 17th 2018

An otherwise healthy 58-year-old woman with a history of breast cancer presents to the clinic with newly diagnosed metastatic disease; eventual abdominal CT showed a mass in the transverse colon with ascites and peritoneal nodularity. What is the best initial systemic treatment for her?

A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer

Ericson Stoen, MD;Peter Kabos, MD;Kelly C. Borden, MD;Regina J. Brown, MD;Virginia F. Borges, MD, MMSc;Jennifer R. Diamond, MD

June 15th 2018

A 35-year-old woman noticed a mass in her right breast and underwent a diagnostic workup, including a mammogram that revealed a 2.4-cm mass and ultrasound that showed two adjacent masses, as well as enlarged axillary lymph nodes.

Early-Stage BRCA2-Linked Breast Cancer Diagnosed in the First Trimester of Pregnancy Associated With a Hypercoagulable State

Jennifer R. Diamond, MD;Christina A. Finlayson, MD;Christiane Thienelt, MD;Peter Kabos, MD;Laura Hardesty, MD;Linda Barbour, MD, MSPH;Catherine E. Klein, MD;Rachel Rabinovitch, MD;Anthony D. Elias, MD;Virginia F. Borges, MD, MMSc

August 17th 2009

This feature examines the case of a patient with newly diagnosed breast cancer in the setting of a first-trimester pregnancy presenting to our multidisciplinary breast cancer clinic.